C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction

Abstract The prognostic role of C-reactive protein levels in patients with a first acute myocardial infarction, an uncomplicated in-hospital course, and the absence of residual ischemia on a predischarge ergometer test and with an echocardiographic ejection fraction ≥50% has not been described. C-reactive protein was determined during hospitalization in 64 patients (55 men, mean age 64.6 ± 10.4 years). The patients were followed up for 13 ± 4 months and the following cardiac events were recorded: cardiac death, new-onset angina pectoris, and recurrent myocardial infarction. Patients who developed cardiac events during the follow-up period had significantly higher C-reactive protein values than patients without events (3.61 ± 2.83 vs 1.48 ± 2.07 mg/dl, p 2.55 mg/dl). In the Cox regression model, only increased C-reactive protein levels were independently related to the incidence of subsequent cardiac events (chi-square 9.8, p = 0.001). Thus, increased C-reactive protein levels are associated with a worse outcome among patients with a first acute myocardial infarction, an uncomplicated in-hospital course without residual ischemia on the ergometer test, and with normal left ventricular function.